1-(2-(2,4-dimethylphenylsulfanyl)phenyl)piperazine,
brintellix,
Lu AA21004,
Lu-AA21004,
LuAA21004,
vortioxetine,
vortioxetine hydrobromide,
Vortioxetine hydrobromide,
960203-27-4,
Vortioxetine (Lu AA21004) HBr,
Brintellix,
Vortioxetine (hydrobromide),
Vortioxetine HBr,
UNII-TKS641KOAY,
Trintellix,
TKS641KOAY,
CHEBI:76015,
Brintellix (TN),
1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine hydrobromide,
1-(2-((2,4-Dimethylphenyl)sulfanyl)phenyl)piperazine monohydrobromide,
1-[2-[(2,4-dimethylphenyl)thio]phenyl]piperazine hydrobromide,
Vortioxetine hydrobromide [USAN],
Lu AA21004 hydrobromide,
vortioxetine monohydrobromide,
C18H22N2S.BrH,
Lu AA 21004 hydrobromide,
SCHEMBL237653,
Lu AA21004 (HBr),
Lu-AA21004-(HBr),
CHEMBL2107387,
Lu-AA-21004,
VNGRUFUIHGGOOM-UHFFFAOYSA-N,
BCP09588,
EX-A2348,
2796AH,
HY-15414A,
MFCD22383961,
s8021,
Vortioxetine hydrobromide (JAN/USAN),
vortioxetine-lu-aa21004-hydrobromide,
AKOS016340374,
CS-1472,
EBD3080710,
HG-0011,
SB16507,
AC-28325,
SC-95551,
Vortioxetine (Lu AA21004) hydrobromide,
AB0165485,
FT-0696676,
SW219360-1,
A12602,
D10185,
W-5911,
Lu AA 21004 hydrobromide;Lu AA21004 hydrobromide,
1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine-hbr,
1-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazine hydrobromide,
4-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]-piperazine hydrobromide,
4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium bromide,
Piperazine, 1-(2-((2,4-dimethylphenyl)thio)phenyl)-, hydrobromide (1:1),
Lu AA 21004|||1-[2-[(2,4-dimethylphenyl)thio]phenyl]-piperazine hydrobromide,
VORTIOXETINE,
ACN-040783,
A2547,
960203-27-4 (HBr),
Vortioxetine hydrobromide, 98.5%, a 5-HT receptor inhibitor - 10MG 10mg,